🇺🇸 FDA
Patent

US 10557118

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

granted A61KA61K2039/585A61K2239/56

Quick answer

US patent 10557118 (Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/585, A61K2239/56, A61K35/12, A61K35/17